News Ardelyx, Inc.

Equities

ARDX

US0396971071

Delayed Nasdaq Other stock markets 03:53:55 2024-04-19 pm EDT			5-day change	1st Jan Change
6.48 ^USD	+0.62%		-8.43%	+4.27%

Apr. 17	Wedbush Raises Price Target on Ardelyx to $14 From $13, Keeps Outperform Rating	MT
Apr. 05	Leerink Partners Initiates Coverage on Ardelyx With Outperform Rating, $14 Price Target	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024	Apr. 18	GL
Wedbush Raises Price Target on Ardelyx to $14 From $13, Keeps Outperform Rating	Apr. 17	MT
Leerink Partners Initiates Coverage on Ardelyx With Outperform Rating, $14 Price Target	Apr. 05	MT
Ardelyx, Inc. Reports Employment Inducement Grants	Mar. 28	GL
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy	Mar. 25	GL
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy	Mar. 25	AQ
Ardelyx, Inc. Announces the Appointment of Mike Kelliher as Executive Vice President, Corporate Development and Strategy	Mar. 25	CI
Ardelyx Insider Sold Shares Worth $664,978, According to a Recent SEC Filing	Mar. 22	MT
Ardelyx, Inc. Reports Employment Inducement Grants	Mar. 12	GL
Ardelyx, Inc. Reports Employment Inducement Grants	Mar. 12	AQ
Ardelyx, Inc. announced that it has received $50 million in funding	Mar. 04	CI
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS	Feb. 28	AQ
Ardelyx to Participate at the Cowen 44th Annual Health Care Conference	Feb. 27	GL
Sector Update: Health Care Stocks Mixed Premarket Friday	Feb. 23	MT
Sector Update: Health Care	Feb. 23	MT
Ardelyx's Q4 Swings to Loss; Revenues Down; Shares Down After-Hours	Feb. 23	MT
Ardelyx: Q4 Earnings Snapshot	Feb. 22	AQ
Ardelyx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
Transcript : Ardelyx, Inc., Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
Ardelyx, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ardelyx, Inc.

Equities

ARDX

US0396971071

Summary

Filters